BioNTech SE (BNTX) Income After Tax (2018 - 2026)
BioNTech SE's Income After Tax came in at $298.54 million for Q3 2026, up 227.0% from $91.3 million a year earlier.
Powered by 
Analysis
BioNTech SE (BNTX) Income After Tax (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, BioNTech SE reported Income After Tax of -$1.63 billion; for FY2025, it came in at -$1.28 billion.
- Going back by year, Income After Tax was -$720.08 million in FY2024, $1.01 billion in FY2023 (-89.9%), $9.94 billion in FY2022 (-18.4%) and $12.18 billion in FY2021.
- The Q3 2026 figure represents the highest quarterly Income After Tax since Q4 2024.
- The fastest year-over-year change in Income After Tax over five years came in Q3 2026 (growth of 227.0%), and the weakest in Q3 2023 (a decline of 89.8%).
- Business Quant data shows BNTX's Income After Tax at -$1.04 billion (Q2 2026), -$707.48 million (Q1 2026) and -$174.37 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | BioNTech SE | 22.05 Bn | -37.46 Bn | 1.36 Bn | 298.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 298.54 Mn |
| Jun 30, 2026 | -1.04 Bn |
| Mar 31, 2026 | -707.48 Mn |
| Dec 31, 2025 | -174.37 Mn |
| Sep 30, 2025 | 91.30 Mn |
| Jun 30, 2025 | -474.06 Mn |
| Mar 31, 2025 | -499.65 Mn |
| Dec 31, 2024 | 366.42 Mn |
| Sep 30, 2024 | 131.02 Mn |
| Jun 30, 2024 | -865.60 Mn |
| Mar 31, 2024 | -378.60 Mn |
| Dec 31, 2023 | 934.45 Mn |
| Sep 30, 2023 | 320.26 Mn |
| Jun 30, 2023 | -690.38 Mn |
| Mar 31, 2023 | 980.18 Mn |
| Dec 31, 2022 | 4.15 Bn |
| Sep 30, 2022 | 3.13 Bn |
| Jun 30, 2022 | 3.17 Bn |
| Mar 31, 2022 | 7.11 Bn |
| Dec 31, 2021 | 7.16 Bn |
API Access
BioNTech SE Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();